← CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV
Market Price
$4.60
Market Cap
$2.36B
P/E Ratio
N/A
Revenue (FY 2025)
↑40.3% YoY
$1.92B
3-Yr CAGR: -17.9%
Net Income
↓-100.0% YoY
N/A
Net Margin: 0.0%
Free Cash Flow
↓-185.3% YoY
-$68.98M
FCF Yield: -2.92%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
0.0%
ROA: 0.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CLOV)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | — | — | — | — | — | — | — | $-159.9M | $-159.9M | — |
| FY 2020 | — | — | — | $-136.4M | — | — | — | $-2.2M | $-2.9M | +98.2% |
| FY 2021 | $1,472.0M | — | $1,468.8M | $-587.8M | -330.9% | — | — | $-282.3M | $-283.0M | -9,593.1% |
| FY 2022 | $3,476.7M | +136.2% | $3,475.4M | $-85.0M | +85.5% | — | — | $-304.6M | $-309.1M | -9.2% |
| FY 2023 | $2,033.7M | -41.5% | $2,033.7M | $-3.2M | +96.2% | — | — | $-35.1M | $-35.7M | +88.4% |
| FY 2024 | $1,371.1M | -32.6% | $179.7M | $3.3M | +201.4% | — | — | $82.5M | $80.9M | +326.4% |
| FY 2025 | $1,924.3M | +40.3% | $1,924.3M | — | -100.0% | — | — | $-66.9M | $-69.0M | -185.3% |
Valuation
Market Price
$4.60
Market Cap
$2.36B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
7.85
FCF Yield
-2.92%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
100.00%
Operating Margin
0.00%
Net Margin
0.00%
Return on Equity (ROE)
0.00%
Return on Assets (ROA)
0.00%
Asset Turnover
3.56x
Revenue 3-Yr CAGR
-17.89%
Financial Health & Liquidity
Current Ratio
3.20
Cash Ratio
23.56
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$78.30M
Total Debt
N/A
Book Value / Share
$0.59
Cash Flow Efficiency
Operating Cash Flow
-$66.93M
Capital Expenditures (CapEx)
$2.04M
Free Cash Flow
-$68.98M
OCF / Revenue
-3.48%
FCF / Revenue
-3.58%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$0.59
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$541.01M
Total Liabilities
$541.01M
Stockholders' Equity
$308.70M
Current Assets
$10.65M
Current Liabilities
$3.32M